Cover Image

Model‐Robust Standardization in Cluster‐Randomized Trials

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Fan Li, Jiaqi Tong, Xi Fang, Chao Cheng, Brennan C. Kahan, Bingkai Wang
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Statistics in Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials
by: Xi Fang, et al.
Published: (2026)

Correction to “Model‐Robust Standardization in Cluster‐Randomized Trials”
Published: (2026)

Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials
by: Jiaqi Tong, et al.
Published: (2025)

What Makes an Estimand Useful? Guidance on the Choice of Intercurrent Event Strategies
by: Brennan C. Kahan, et al.
Published: (2026)

On Anticipation Effect in Stepped Wedge Cluster Randomized Trials
by: Hao Wang, et al.
Published: (2026)

Analysis of Stepped‐Wedge Cluster Randomized Trials: A Tutorial Using Marginal Models
by: Elizabeth L. Turner, et al.
Published: (2026)

Time‐Varying Treatment Effect Models in Stepped‐Wedge Cluster‐Randomized Trials With Multiple Interventions
by: Zhe Chen, et al.
Published: (2026)

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
by: Yuwei Cheng, et al.
Published: (2026)

Analysis of Cohort Stepped Wedge Cluster‐Randomized Trials With Nonignorable Dropout via Joint Modeling
by: Alessandro Gasparini, et al.
Published: (2025)

Designing Stepped Wedge Cluster Randomized Trials With a Baseline Measurement of the Outcome
by: Kendra Davis‐Plourde, et al.
Published: (2025)

Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
by: Yunyi Liu, et al.
Published: (2026)

Model-robust standardization in cluster-randomized trials
by: Li, Fan, et al.
Published: (2025)

Categorisation of continuous covariates for stratified randomisation: How should we adjust?
by: Thomas R. Sullivan, et al.
Published: (2024)

Using Propensity Score Weighting With Clustered Data When the Treatment Is Applied at the Level of the Cluster and Outcomes Are Assessed at the Level of the Individual: The Observational Analog of Cluster Randomization Trials
by: Peter C. Austin
Published: (2026)

Handling Missing Outcome Data in Cluster Randomized Trials With Both Individual‐ and Cluster‐Level Dropout
by: Analissa Avila, et al.
Published: (2025)

Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies
by: Melody A. Owen, et al.
Published: (2025)

Cluster‐Level Analyses to Estimate a Risk Difference in a Cluster Randomized Trial With Confounding Individual‐Level Covariates: A Simulation Study
by: Jules Antoine Pereira Macedo, et al.
Published: (2025)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
by: Xiaotian Chen, et al.
Published: (2025)

Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials
by: Liwen Wu, et al.
Published: (2025)

Dynamic Borrowing From Historical Controls via the Synthetic Prior With Covariates in Randomized Clinical Trials
by: Daniel E. Schwartz, et al.
Published: (2026)

The Cox Model With Adaptive Fused Group Bridge Penalty to Incorporate Historical Data Into the Analysis of Clinical Trials With an Application to BMT CTN 1101
by: Xi Fang, et al.
Published: (2025)

Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials
by: Jingyan Fu, et al.
Published: (2025)

Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
by: Jingya Gao, et al.
Published: (2024)

Semiparametric Estimation of Relative Causal Effects in Randomized Controlled Trials With Noncompliance
by: Wenli Liu, et al.
Published: (2025)

Safety‐Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials
by: Maria Vittoria Chiaruttini, et al.
Published: (2026)

A Saddlepoint Framework for Accurate Inference in Multicenter Clinical Trials With Imbalanced Clusters
by: Haidy A. Newer
Published: (2026)

Dynamic Borrowing With a Bias‐Tolerance Cap in Augmented Randomized Controlled Trials
by: Kota Sawada, et al.
Published: (2026)

Modern Causal Inference Approaches to Improve Power for Subgroup Analysis in Randomized Controlled Trials
by: Antonio D'Alessandro, et al.
Published: (2026)

A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards
by: Florian Klinglmüller, et al.
Published: (2025)

Moving Toward Best Practice When Using Propensity Score Weighting in Survey Observational Studies
by: Yukang Zeng, et al.
Published: (2026)

Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis
by: Ruoyuan Qian, et al.
Published: (2025)

MARGO: Machine Learning‐Assisted Adaptive Randomization for Group Sequential Trials Based on Overlap Weights
by: Yeonhee Park, et al.
Published: (2025)

A Framework for Generating Realistic Synthetic Tabular Data in a Randomized Controlled Trial Setting
by: Niki Z. Petrakos, et al.
Published: (2025)

Variability in Causal Effects and Noncompliance in a Multisite Trial: A Bivariate Hierarchical Generalized Random Coefficients Model for a Binary Outcome
by: Xinxin Sun, et al.
Published: (2024)

A Partially Randomized Patient Preference, Sequential, Multiple‐Assignment, Randomized Trial Design Analyzed via Weighted and Replicated Frequentist and Bayesian Methods
by: Marianthie Wank, et al.
Published: (2024)

Futility Monitoring in Clinical Trials
by: Ana M. Ortega‐Villa, et al.
Published: (2025)

Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials
by: Godwin Yung, et al.
Published: (2025)

Group Sequential Trial Design Using Stepwise Monte Carlo for Increased Flexibility and Robustness
by: Amitay Kamber, et al.
Published: (2025)

Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints
by: Hyejung Jung, et al.
Published: (2026)

Synergy Area With FDR ‐Controlled Evaluation ( SAFE ) to Robustly Assess Safety Profile in Clinical Trials
by: Tianyu Zhan, et al.
Published: (2026)